Analyst Price Targets — BTMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 16, 2026 12:14 pm | Les Sulewski | Truist Financial | $4.00 | $2.01 | TheFly | Biote price target lowered to $4 from $5 at Truist |
| March 12, 2026 1:29 pm | — | National Bank | $2.50 | $1.58 | StreetInsider | biote Corp. (BTMD) PT Lowered to $2.50 at TD Cowen |
| January 7, 2026 12:20 pm | — | Truist Financial | $5.00 | $2.54 | TheFly | Biote price target lowered to $5 from $6 at Truist |
| June 21, 2024 6:37 am | Gregory Fraser | Truist Financial | $9.00 | $7.23 | StreetInsider | Truist Securities Reiterates Buy Rating on biote Corp. (BTMD) |
| March 13, 2024 5:46 am | Kaumil Gajrawala | Jefferies | $8.24 | $6.09 | StreetInsider | biote Corp. (BTMD) PT Raised to $8.24 at Jefferies |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for BTMD

biote Corp. (BTMD) Q4 2025 Earnings Call Transcript

biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.1 per share a year ago.

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the fourth quarter and full year ended December 31, 2025. “Over the past twelve months, Biote has focused on our strategic priorities which are designed to drive sustainable profitable growth and…

IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients' lives by providing hormone replacement therapy and healthy aging solutions, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 11, 2026, after the close of the market. A conference call to discuss the firm's results…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BTMD.
U.S. House Trading
No House trades found for BTMD.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
